{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:16:27Z","timestamp":1786986987471,"version":"build-2736575974"},"reference-count":76,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007497","name":"Biosense Webster","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.cjca.2018.07.483","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T12:41:19Z","timestamp":1534768879000},"page":"1437-1448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Atrial Fibrillation and Heart Failure: Untangling a Modern Gordian Knot"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8332-8551","authenticated-orcid":false,"given":"Allan C.","family":"Skanes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony S.L.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2018.07.483_bib1","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.108.821306","article-title":"Atrial fibrillation and heart failure: treatment considerations for a dual epidemic","volume":"119","author":"Anter","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.07.483_bib2","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1161\/CIRCULATIONAHA.116.026054","article-title":"Treatment of patients with atrial fibrillation and heart failure with reduced ejection fraction","volume":"135","author":"Verma","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.07.483_bib3","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.hlc.2017.05.117","article-title":"Atrial fibrillation and heart failure - cause or effect?","volume":"26","author":"Prabhu","year":"2017","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.cjca.2018.07.483_bib4","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","article-title":"Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction","volume":"133","author":"Santhanakrishnan","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.07.483_bib5","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jacc.2015.08.038","article-title":"Arrhythmia-induced cardiomyopathies: mechanisms, recognition, and management","volume":"66","author":"Gopinathannair","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2018.07.483_bib6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pharmthera.2016.10.019","article-title":"Atrial fibrillation in heart failure with preserved ejection fraction: insights into mechanisms and therapeutics","volume":"176","author":"Patel","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cjca.2018.07.483_bib7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pcad.2015.07.004","article-title":"Atrial fibrillation and heart failure: update 2015","volume":"58","author":"Thihalolipavan","year":"2015","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cjca.2018.07.483_bib8","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/eurjhf\/hfp085","article-title":"A\u00a0meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure","volume":"11","author":"Mamas","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2018.07.483_bib9","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics-2018 update: a report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.07.483_bib10","first-page":"1342","article-title":"2017 comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure","volume":"33","author":"Ezekowitz","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2018.07.483_bib11","doi-asserted-by":"crossref","first-page":"i4482","DOI":"10.1136\/bmj.i4482","article-title":"Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis","volume":"354","author":"Odutayo","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2018.07.483_bib12","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1161\/CIRCULATIONAHA.112.000491","article-title":"Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study","volume":"128","author":"Marijon","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.07.483_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jchf.2013.11.002","article-title":"Outcomes of Medicare beneficiaries with heart failure and atrial fibrillation","volume":"2","author":"Khazanie","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2018.07.483_bib14","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.07.483_bib15","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jchf.2017.04.004","article-title":"Modifiable risk factors for incident heart failure in atrial fibrillation","volume":"5","author":"Chatterjee","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2018.07.483_bib16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/eurheartj\/eht483","article-title":"Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke","volume":"35","author":"Piccini","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2018.07.483_bib17","first-page":"41","article-title":"Atrial electrophysiological remodeling and fibrillation in heart failure","volume":"10","author":"Pandit","year":"2016","journal-title":"Clin Med Insights Cardiol"},{"key":"10.1016\/j.cjca.2018.07.483_bib18","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/cvr\/cvv001","article-title":"Atrial fibrillation: effects beyond the atrium?","volume":"105","author":"Wijesurendra","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2018.07.483_bib19","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/CIRCRESAHA.114.303211","article-title":"The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms","volume":"114","author":"Andrade","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2018.07.483_bib20","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/S0735-1097(02)02373-2","article-title":"Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women","volume":"40","author":"Tsang","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2018.07.483_bib21","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0002-9149(02)02864-3","article-title":"Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden","volume":"90","author":"Tsang","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2018.07.483_bib22","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1161\/01.CIR.0000066915.15187.51","article-title":"Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation","volume":"107","author":"Verheule","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.07.483_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.CIR.100.1.87","article-title":"Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort","volume":"100","author":"Li","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.07.483_bib24","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.CIR.92.7.1954","article-title":"Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats","volume":"92","author":"Wijffels","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.07.483_bib25","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1161\/01.CIR.91.5.1588","article-title":"Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation","volume":"91","author":"Morillo","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.07.483_bib26","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/01.RES.81.6.1045","article-title":"Tachycardia-induced changes in na+ current in a chronic dog model of atrial fibrillation","volume":"81","author":"Gaspo","year":"1997","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2018.07.483_bib27","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1161\/01.CIR.96.11.4027","article-title":"Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model","volume":"96","author":"Gaspo","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.07.483_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/415219a","article-title":"New ideas about atrial fibrillation 50 years on","volume":"415","author":"Nattel","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cjca.2018.07.483_bib29","doi-asserted-by":"crossref","first-page":"2D","DOI":"10.1016\/S0002-9149(02)03373-8","article-title":"Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy","volume":"91","author":"Maisel","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2018.07.483_bib30","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","article-title":"Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND","volume":"34","author":"Brouwers","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2018.07.483_bib31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/jamacardio.2017.4987","article-title":"Association of cardiovascular biomarkers with incident heart failure with preserved and reduced ejection fraction","volume":"3","author":"de Boer","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjca.2018.07.483_bib32","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ijcard.2015.10.220","article-title":"Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: a systematic review and meta-analysis of death and adverse outcomes","volume":"203","author":"Kotecha","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2018.07.483_bib33","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/CIRCULATIONAHA.105.541078","article-title":"Age- and gender-related ventricular-vascular stiffening: a community-based study","volume":"112","author":"Redfield","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.07.483_bib34","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.jacc.2015.03.043","article-title":"Patient selection in heart failure with preserved ejection fraction clinical trials","volume":"65","author":"Kelly","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2018.07.483_bib35","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.113.001475","article-title":"Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study","volume":"128","author":"Zakeri","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.07.483_bib36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCHEARTFAILURE.112.972828","article-title":"Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction","volume":"6","author":"Ho","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2018.07.483_bib37","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jacc.2015.06.1314","article-title":"Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: a community-based study from the Netherlands","volume":"66","author":"Vermond","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2018.07.483_bib38","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/CIRCULATIONAHA.117.030093","article-title":"High prevalence of occult heart failure with preserved ejection fraction among patients with atrial fibrillation and dyspnea","volume":"137","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.07.483_bib39","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.jacc.2004.11.070","article-title":"Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis","volume":"45","author":"Healey","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2018.07.483_bib40","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacc.2011.11.063","article-title":"Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure) study","volume":"59","author":"Swedberg","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2018.07.483_bib41","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.jacc.2017.10.014","article-title":"Eplerenone reduces atrial fibrillation burden without preventing atrial electrical remodeling","volume":"70","author":"Takemoto","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2018.07.483_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jchf.2012.09.002","article-title":"Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis","volume":"1","author":"Rienstra","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2018.07.483_bib43","first-page":"1114","article-title":"2014 focused update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation","volume":"30","author":"Verma","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2018.07.483_bib44","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.07.483_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165790","article-title":"Patient-reported outcomes for quality of life assessment in atrial fibrillation: a systematic review of measurement properties","volume":"11","author":"Kotecha","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.cjca.2018.07.483_bib46","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/ejhf.343","article-title":"Non-vitamin k antagonist oral anticoagulants (NOACS) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials","volume":"17","author":"Xiong","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2018.07.483_bib47","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","article-title":"Rhythm control versus rate control for atrial fibrillation and heart failure","volume":"358","author":"Roy","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2018.07.483_bib48","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A\u00a0comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2018.07.483_bib49","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A\u00a0comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"Van Gelder","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2018.07.483_bib50","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/01.CIR.101.10.1138","article-title":"Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis","volume":"101","author":"Wood","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.07.483_bib51","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0735-1097(92)90003-6","article-title":"Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators","volume":"20","author":"Flaker","year":"1992","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2018.07.483_bib52","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/eurjhf\/hfs036","article-title":"Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis of biventricular vs. right ventricular pacing mode","volume":"14","author":"Chatterjee","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2018.07.483_bib53","article-title":"Clinical outcomes after ablation of the AV junction in patients with atrial fibrillation: impact of cardiac resynchronization therapy","volume":"6","author":"Mittal","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2018.07.483_bib54","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCEP.111.967810","article-title":"Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis and systematic review","volume":"5","author":"Chatterjee","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2018.07.483_bib55","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1001\/jama.288.24.3115","article-title":"Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) trial","volume":"288","author":"Wilkoff","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2018.07.483_bib56","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1161\/01.CIR.0000150336.86033.8D","article-title":"Detrimental ventricular remodeling in patients with congenital complete heart block and chronic right ventricular apical pacing","volume":"110","author":"Thambo","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.07.483_bib57","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1161\/01.CIR.0000072769.17295.B1","article-title":"Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction","volume":"107","author":"Sweeney","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.07.483_bib58","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/europace\/eus193","article-title":"Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis","volume":"14","author":"Stavrakis","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2018.07.483_bib59","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJMoa1210356","article-title":"Biventricular pacing for atrioventricular block and systolic dysfunction","volume":"368","author":"Curtis","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2018.07.483_bib60","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.jacc.2016.02.051","article-title":"Improvement in clinical outcomes with biventricular versus right ventricular pacing: the BLOCK HF study","volume":"67","author":"Curtis","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2018.07.483_bib61","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0735-1097(02)01779-5","article-title":"Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing","volume":"39","author":"Leon","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2018.07.483_bib62","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/01.CIR.0000121736.16643.11","article-title":"Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (affirm) study","volume":"109","author":"Corley","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.07.483_bib63","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.jacc.2010.01.023","article-title":"Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation","volume":"55","author":"Talajic","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2018.07.483_bib64","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1161\/01.CIR.98.23.2574","volume":"98","author":"Deedwania","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.07.483_bib65","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/hrt.2008.158931","article-title":"A\u00a0randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study)","volume":"95","author":"Shelton","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2018.07.483_bib66","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJM199909163411201","article-title":"Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish investigations of arrhythmia and mortality on dofetilide study group","volume":"341","author":"Torp-Pedersen","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2018.07.483_bib67","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJMoa0708234","article-title":"Pulmonary-vein isolation for atrial fibrillation in patients with heart failure","volume":"359","author":"Khan","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2018.07.483_bib68","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.hlc.2015.02.025","article-title":"Pulmonary vein isolation compared to rate control in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"24","author":"Vaidya","year":"2015","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.cjca.2018.07.483_bib69","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.hlc.2014.09.012","article-title":"Catheter ablation of atrial fibrillation in patients with concomitant left ventricular impairment: a systematic review of efficacy and effect on ejection fraction","volume":"24","author":"Ganesan","year":"2015","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.cjca.2018.07.483_bib70","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1161\/CIRCEP.114.001938","article-title":"Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis","volume":"7","author":"Anselmino","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2018.07.483_bib71","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jacc.2017.08.041","article-title":"Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: The CAMERA-MRI study","volume":"70","author":"Prabhu","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2018.07.483_bib72","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","article-title":"Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial","volume":"133","author":"Di Biase","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.07.483_bib73","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2018.07.483_bib74","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.118.034583","article-title":"Building castles in the sky: catheter ablation in patients with atrial fibrillation and chronic heart failure","author":"Packer","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.07.483_bib75","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2018.07.483_bib76","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/jce.12535","article-title":"Efficacy of amiodarone in patients with atrial fibrillation with and without left ventricular dysfunction: a pooled analysis of AFFIRM and AF-CHF trials","volume":"25","author":"Cadrin-Tourigny","year":"2014","journal-title":"J\u00a0Cardiovasc Electrophysiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X18310572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X18310572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:38:50Z","timestamp":1760107130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X18310572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":76,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0828282X18310572"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2018.07.483","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial Fibrillation and Heart Failure: Untangling a Modern Gordian Knot","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2018.07.483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}